Del 242 - Progress in Brain Research

Psychedelic Neuroscience

Inbunden, Engelska, 2018

4 089 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

We are in the midst of what is being called the 'psychedelic renaissance' with growing interest into how psychedelics alter consciousness, brain function and brain connectivity. The acute, often profound, effects of the psychedelic experience can induce lasting improvements in mental health demonstrating that chemistry forms the basis of mystical experience, consciousness and mental wellbeing.

This volume is a collection of chapters by world leaders in fields of neurobiology, neuropsychiatry, psychology, ethnography and pharmacology, addressing the neurobiological mechanisms of action of various classic and atypical psychedelics, their therapeutic potential as well as the possible risks associated with their use

Produktinformation

Utgivningsdatum2018-11-26
Mått191 x 235 x undefined mm
Vikt720 g
FormatInbunden
SpråkEngelska
SerieProgress in Brain Research
Antal sidor261
FörlagElsevier Science
ISBN9780128142554

Tillhör följande kategorier

Dr. Tanya Calvey has a background in evolutionary neurobiology and lectures morphological anatomy in the Faculty of Health Sciences, University of the Witwatersrand. Tanya’s current research is on the neuropsychopharmacology of ibogaine and substance use disorders in humans and animals. Her research team is multidisciplinary and her research is funded by the South African Medical Research Council, the South African National Research Foundation and the International Society for Neurochemistry. Tanya is also actively involved in developing neuroscience research in Africa. She is the Secretary of the Southern African Neuroscience Society and the co-founder of the Wits Cortex Club.

1. An introduction to psychedelic neuroscienceTanya Calvey and Fleur M. Howells2. The renaissance in psychedelic research: What do preclinical models have to offerKevin S. Murnane3. D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disordersDanilo De Gregorio, Justine P. Enns, Nicolas A. Nuñez, Luca Posa and Gabriella Gobbi4. Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decompositionSelen Atasoy, Jakub Vohryzek, Gustavo Deco, Robin L. Carhart-Harris and Morten L. Kringelbach5. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorderJoseph Barsuglia, Martin Polanco, Robert Palmer, Benjamin Malcolm, Benjamin Kelmendi and Tanya Calvey6. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brainFelix Müller, Matthias E. Liechti, Undine E. Lang and Stefan Borgwardt7. Neurocognitive effects of cannabis: Lessons learned from human experimental studiesMarco Colizzi and Sagnik Bhattacharyya8. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangersJohn Martin Corkery